Filter
724
Filtered Results: 724
Text search:
VIDAL
Featured
Recommendations
105
New Publications
190
Language
Document type
No document type
315
Guidelines
195
Studies & Reports
92
Manuals
53
Fact sheets
24
Strategic & Response Plan
19
Training Material
14
Infographics
6
Situation Updates
3
Online Courses
2
Resource Platforms
1
Countries / Regions
India
47
Latin America and the Carribbean
27
Paraguay
24
Global
20
Argentina
19
Venezuela
16
South Africa
15
Kenya
14
Peru
13
Uganda
13
Ethiopia
13
Philippines
11
Liberia
10
Colombia
9
Nigeria
9
Brazil
9
Ecuador
9
Nepal
8
Rwanda
8
Africa
8
Tanzania
8
Sierra Leone
7
Congo, Democratic Republic of
7
Bolivia
7
El Salvador
6
Spain
6
Bangladesh
6
Zambia
6
Zimbabwe
5
Cameroon
4
Senegal
4
Burkina Faso
4
Yemen
4
Myanmar / Burma
4
Ghana
3
Syria
3
Malawi
3
Guinea
3
Haiti
3
West and Central Africa
3
Russia
3
Mali
3
Thailand
2
Ukraine
2
Chile
2
Mozambique
2
Cambodia
2
Guinea-Bissau
2
Germany
2
South–East Asia Region
2
United Kingdom
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Greece
2
Central African Republic
2
Botswana
2
South Sudan
2
Indonesia
2
Somalia
2
Guatemala
2
Mexico
1
Lesotho
1
Benin
1
China
1
Niger
1
Afghanistan
1
USA
1
Middle East and North Africa
1
Western and Central Europe
1
North America
1
Uruguay
1
Portugal
1
Israel
1
Lebanon
1
Eastern Europe
1
Namibia
1
Egypt
1
Palestine
1
Honduras
1
Angola
1
Libya
1
Solomon Islands
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
317
Clinical Guidelines
102
Women & Child Health
43
Public Health
35
Key Resources
26
Capacity Building
17
Pharmacy & Technologies
11
Toolboxes
COVID-19
118
Pharmacy
52
TB
44
HIV
30
Rapid Response
27
NTDs
27
Mental Health
26
Ebola & Marburg
25
Caregiver
25
AMR
19
NCDs
16
Planetary Health
12
Disability
11
Polio
10
Global Health Education
9
Refugee
7
Conflict
7
Natural Hazards
6
Zika
5
Cholera
4
Specific Hazards
3
Malaria
2
Health Financing Toolbox
1
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
Campaña Nacional de Vacunación contra la COVID-19
Fourth edition
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
A quick reference guide for health authorities and health-care workers
Revised 2015
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
